San Francisco, CA
Summary
This company specializes in developing innovative cancer therapies using a proprietary platform that employs click chemistry to deliver drugs directly to tumors. Their approach minimizes side effects and enhances the effectiveness of treatments by separating the drug payload from the targeting mechanism until it reaches the tumor site. This technology, which has been validated in clinical settings, aims to improve therapeutic outcomes for patients with limited treatment options.
8 of 8 checks passed
Label
Value
Active Dates
9.8 years — Since Mar 2015
Web Hosting
Platform
E-Mail Provider
Google GSuite
NAICS Code
325414
SIC 4 Digit Code
2836
SIC 2 Digit Code
28
Industry
1. Biotechnology focused on cancer treatment.
2. Biological Product (except Diagnostic) Manufacturing
Vendor
Source
Microsoft
TXT Record
TXT Record
Smartsheet
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|